nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—ABCC2—Vincristine—sarcoma	0.125	0.251	CbGbCtD
Pranlukast—ABCC2—Etoposide—sarcoma	0.114	0.23	CbGbCtD
Pranlukast—CYP3A4—Thiotepa—sarcoma	0.0822	0.166	CbGbCtD
Pranlukast—ABCC2—Doxorubicin—sarcoma	0.0779	0.157	CbGbCtD
Pranlukast—CYP3A4—Mitoxantrone—sarcoma	0.0354	0.0713	CbGbCtD
Pranlukast—CYP3A4—Vincristine—sarcoma	0.0243	0.0491	CbGbCtD
Pranlukast—CYP3A4—Etoposide—sarcoma	0.0223	0.045	CbGbCtD
Pranlukast—CYP3A4—Doxorubicin—sarcoma	0.0152	0.0307	CbGbCtD
Pranlukast—RNASE3—hematopoietic system—sarcoma	0.0114	0.0643	CbGeAlD
Pranlukast—IL5—hematopoietic system—sarcoma	0.0104	0.0584	CbGeAlD
Pranlukast—IL5—connective tissue—sarcoma	0.01	0.0562	CbGeAlD
Pranlukast—MUC2—embryo—sarcoma	0.00895	0.0503	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—sarcoma	0.00805	0.0452	CbGeAlD
Pranlukast—MUC2—connective tissue—sarcoma	0.00769	0.0432	CbGeAlD
Pranlukast—RNASE3—tendon—sarcoma	0.00757	0.0425	CbGeAlD
Pranlukast—NFKB1—mammary gland—sarcoma	0.00747	0.042	CbGeAlD
Pranlukast—RNASE3—bone marrow—sarcoma	0.00733	0.0412	CbGeAlD
Pranlukast—IL5—lymphoid tissue—sarcoma	0.00731	0.0411	CbGeAlD
Pranlukast—IL5—testis—sarcoma	0.00569	0.032	CbGeAlD
Pranlukast—NFKB1—myometrium—sarcoma	0.0053	0.0298	CbGeAlD
Pranlukast—NFKB1—seminal vesicle—sarcoma	0.00479	0.0269	CbGeAlD
Pranlukast—NFKB1—hematopoietic system—sarcoma	0.00455	0.0256	CbGeAlD
Pranlukast—CYSLTR1—hematopoietic system—sarcoma	0.00447	0.0251	CbGeAlD
Pranlukast—NFKB1—connective tissue—sarcoma	0.00438	0.0246	CbGeAlD
Pranlukast—MUC2—testis—sarcoma	0.00438	0.0246	CbGeAlD
Pranlukast—MUC2—liver—sarcoma	0.00414	0.0233	CbGeAlD
Pranlukast—IL5—lymph node—sarcoma	0.00413	0.0232	CbGeAlD
Pranlukast—CYSLTR1—smooth muscle tissue—sarcoma	0.00394	0.0221	CbGeAlD
Pranlukast—NFKB1—cardiac atrium—sarcoma	0.00346	0.0194	CbGeAlD
Pranlukast—NFKB1—uterus—sarcoma	0.00344	0.0193	CbGeAlD
Pranlukast—CYSLTR1—uterus—sarcoma	0.00338	0.019	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—sarcoma	0.00321	0.018	CbGeAlD
Pranlukast—TNF—lymph node—sarcoma	0.00317	0.0178	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—sarcoma	0.00315	0.0177	CbGeAlD
Pranlukast—NFKB1—tendon—sarcoma	0.00301	0.0169	CbGeAlD
Pranlukast—NFKB1—bone marrow—sarcoma	0.00292	0.0164	CbGeAlD
Pranlukast—CYSLTR1—bone marrow—sarcoma	0.00287	0.0161	CbGeAlD
Pranlukast—NFKB1—testis—sarcoma	0.0025	0.014	CbGeAlD
Pranlukast—NFKB1—liver—sarcoma	0.00236	0.0133	CbGeAlD
Pranlukast—CYP2C9—mammary gland—sarcoma	0.00196	0.011	CbGeAlD
Pranlukast—NFKB1—lymph node—sarcoma	0.00181	0.0102	CbGeAlD
Pranlukast—CYSLTR1—lymph node—sarcoma	0.00178	0.00998	CbGeAlD
Pranlukast—CYP2C9—hematopoietic system—sarcoma	0.00119	0.00669	CbGeAlD
Pranlukast—ABCC2—tendon—sarcoma	0.00118	0.00665	CbGeAlD
Pranlukast—ABCC2—testis—sarcoma	0.00098	0.0055	CbGeAlD
Pranlukast—ABCC2—liver—sarcoma	0.000926	0.0052	CbGeAlD
Pranlukast—CYP3A4—hematopoietic system—sarcoma	0.000908	0.0051	CbGeAlD
Pranlukast—ABCC2—lymph node—sarcoma	0.00071	0.00399	CbGeAlD
Pranlukast—CYP2C9—liver—sarcoma	0.000617	0.00347	CbGeAlD
Pranlukast—CYP3A4—liver—sarcoma	0.000471	0.00264	CbGeAlD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000194	0.000595	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—HRAS—sarcoma	0.000193	0.000593	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCR4—sarcoma	0.000193	0.000591	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000193	0.000591	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—HRAS—sarcoma	0.000192	0.000589	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—VEGFA—sarcoma	0.000191	0.000587	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PTPRC—sarcoma	0.000191	0.000586	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—JUN—sarcoma	0.000191	0.000585	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ATF1—sarcoma	0.000191	0.000585	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NRAS—sarcoma	0.000189	0.00058	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—sarcoma	0.000188	0.000578	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000188	0.000577	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PLCG1—sarcoma	0.000187	0.000573	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—NRAS—sarcoma	0.000186	0.000572	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—NRAS—sarcoma	0.000186	0.000569	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000184	0.000565	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFC—sarcoma	0.000183	0.000562	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD34—sarcoma	0.000178	0.000547	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—NRAS—sarcoma	0.000178	0.000546	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CREB1—sarcoma	0.000175	0.000536	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MYC—sarcoma	0.000175	0.000536	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000174	0.000534	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—FOXO1—sarcoma	0.000174	0.000534	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000174	0.000534	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—JUN—sarcoma	0.000174	0.000533	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CTNNB1—sarcoma	0.000173	0.000532	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—MYC—sarcoma	0.000173	0.00053	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000173	0.000529	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—MDM2—sarcoma	0.000172	0.000529	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—EGFR—sarcoma	0.000171	0.000524	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.00017	0.000522	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—sarcoma	0.00017	0.000521	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.00017	0.00052	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—EGFR—sarcoma	0.000169	0.000519	CbGpPWpGaD
Pranlukast—IL5—Immune System—KIT—sarcoma	0.000168	0.000515	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—HRAS—sarcoma	0.000167	0.000514	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—NRAS—sarcoma	0.000165	0.000505	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—JUN—sarcoma	0.000164	0.000503	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—KRAS—sarcoma	0.000163	0.000499	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—EGFR—sarcoma	0.000162	0.000497	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—MDM2—sarcoma	0.000162	0.000496	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—KRAS—sarcoma	0.000161	0.000492	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—KRAS—sarcoma	0.00016	0.00049	CbGpPWpGaD
Pranlukast—IL5—Immune System—CREB1—sarcoma	0.00016	0.00049	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000156	0.000478	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000155	0.000474	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FOXO1—sarcoma	0.000154	0.000471	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—HRAS—sarcoma	0.000154	0.000471	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PDGFRB—sarcoma	0.000153	0.00047	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	0.000153	0.00047	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000153	0.000468	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000152	0.000466	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PDGFRA—sarcoma	0.000151	0.000463	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—EGFR—sarcoma	0.00015	0.00046	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—JUN—sarcoma	0.00015	0.000459	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF1R—sarcoma	0.00015	0.000459	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000148	0.000455	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000148	0.000454	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FOXO1—sarcoma	0.000148	0.000453	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PDGFRB—sarcoma	0.000147	0.000452	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL2—sarcoma	0.000147	0.000451	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000147	0.00045	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FLT1—sarcoma	0.000147	0.000449	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PDGFRA—sarcoma	0.000145	0.000445	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—sarcoma	0.000145	0.000444	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000144	0.000442	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PLCG1—sarcoma	0.000144	0.000442	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KDR—sarcoma	0.000144	0.000441	CbGpPWpGaD
Pranlukast—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000144	0.00044	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—sarcoma	0.000144	0.00044	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FOXO1—sarcoma	0.000142	0.000437	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—IL2—sarcoma	0.000142	0.000437	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PDGFRB—sarcoma	0.000142	0.000436	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—sarcoma	0.000142	0.000435	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—KRAS—sarcoma	0.000142	0.000435	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—NRAS—sarcoma	0.000141	0.000434	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PDGFRA—sarcoma	0.00014	0.000429	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCR4—sarcoma	0.000138	0.000424	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—HRAS—sarcoma	0.000138	0.000424	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ATF1—sarcoma	0.000137	0.00042	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	0.000136	0.000418	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000133	0.000407	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—FOXO1—sarcoma	0.000133	0.000407	CbGpPWpGaD
Pranlukast—IL5—Immune System—MDM2—sarcoma	0.000132	0.000405	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MYC—sarcoma	0.000132	0.000404	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—sarcoma	0.000131	0.000401	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—sarcoma	0.000131	0.000401	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	0.00013	0.000399	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL2—sarcoma	0.000129	0.000396	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000129	0.000396	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTPRC—sarcoma	0.000129	0.000395	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—EGFR—sarcoma	0.000129	0.000395	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000128	0.000393	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CREB1—sarcoma	0.000126	0.000387	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PLCG1—sarcoma	0.000126	0.000387	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—SRC—sarcoma	0.000126	0.000387	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CREB1—sarcoma	0.000125	0.000385	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—NRAS—sarcoma	0.000123	0.000378	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TLE1—sarcoma	0.000123	0.000377	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—KRAS—sarcoma	0.000122	0.000373	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NRAS—sarcoma	0.000121	0.000372	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—HRAS—sarcoma	0.000121	0.00037	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ATF1—sarcoma	0.00012	0.000368	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000119	0.000365	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2—sarcoma	0.000118	0.000362	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KDR—sarcoma	0.000118	0.000361	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP2—sarcoma	0.000117	0.00036	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KIT—sarcoma	0.000117	0.000359	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000116	0.000357	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—sarcoma	0.000115	0.000354	CbGpPWpGaD
Pranlukast—IL5—Immune System—JUN—sarcoma	0.000115	0.000352	CbGpPWpGaD
Pranlukast—IL5—Immune System—CTNNB1—sarcoma	0.000114	0.00035	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KIT—sarcoma	0.000112	0.000345	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CREB1—sarcoma	0.000111	0.000342	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—EGFR—sarcoma	0.00011	0.000339	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.00011	0.000337	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KDR—sarcoma	0.00011	0.000336	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KIT—sarcoma	0.000109	0.000333	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—NRAS—sarcoma	0.000109	0.000333	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—sarcoma	0.000108	0.000332	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1R—sarcoma	0.000107	0.000329	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CREB1—sarcoma	0.000107	0.000328	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—KRAS—sarcoma	0.000106	0.000326	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KRAS—sarcoma	0.000104	0.00032	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFC—sarcoma	0.000104	0.000318	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CREB1—sarcoma	0.000103	0.000317	CbGpPWpGaD
Pranlukast—IL5—Immune System—SRC—sarcoma	0.000103	0.000316	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FOXO1—sarcoma	0.000102	0.000313	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—sarcoma	0.000102	0.000313	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PDGFRB—sarcoma	0.000102	0.000313	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PDGFRA—sarcoma	0.0001	0.000308	CbGpPWpGaD
Pranlukast—IL5—Immune System—NRAS—sarcoma	9.91e-05	0.000304	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—sarcoma	9.89e-05	0.000303	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EGFR—sarcoma	9.89e-05	0.000303	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	9.76e-05	0.000299	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CREB1—sarcoma	9.62e-05	0.000295	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—KRAS—sarcoma	9.34e-05	0.000286	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—sarcoma	9.28e-05	0.000285	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MDM2—sarcoma	9.22e-05	0.000283	CbGpPWpGaD
Pranlukast—IL5—Immune System—EGFR—sarcoma	9.03e-05	0.000277	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HRAS—sarcoma	9.02e-05	0.000277	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CTNNB1—sarcoma	9.01e-05	0.000276	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP2—sarcoma	8.95e-05	0.000275	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FOXO1—sarcoma	8.95e-05	0.000274	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PDGFRB—sarcoma	8.93e-05	0.000274	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—HRAS—sarcoma	8.87e-05	0.000272	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—MDM2—sarcoma	8.86e-05	0.000272	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PDGFRA—sarcoma	8.8e-05	0.00027	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MDM2—sarcoma	8.55e-05	0.000262	CbGpPWpGaD
Pranlukast—IL5—Immune System—KRAS—sarcoma	8.53e-05	0.000262	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KDR—sarcoma	8.45e-05	0.000259	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FLT1—sarcoma	8.3e-05	0.000254	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PLCG1—sarcoma	8.16e-05	0.00025	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—SRC—sarcoma	8.14e-05	0.00025	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—JUN—sarcoma	8.02e-05	0.000246	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CTNNB1—sarcoma	7.95e-05	0.000244	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRAS—sarcoma	7.94e-05	0.000243	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—sarcoma	7.93e-05	0.000243	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCR4—sarcoma	7.84e-05	0.00024	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—NRAS—sarcoma	7.83e-05	0.00024	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KIT—sarcoma	7.79e-05	0.000239	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—NRAS—sarcoma	7.79e-05	0.000239	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ATF1—sarcoma	7.75e-05	0.000238	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—sarcoma	7.64e-05	0.000234	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCND1—sarcoma	7.44e-05	0.000228	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—JUN—sarcoma	7.43e-05	0.000228	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CREB1—sarcoma	7.41e-05	0.000227	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CTNNB1—sarcoma	7.37e-05	0.000226	CbGpPWpGaD
Pranlukast—IL5—Immune System—HRAS—sarcoma	7.25e-05	0.000222	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—SRC—sarcoma	7.19e-05	0.00022	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EGFR—sarcoma	7.14e-05	0.000219	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EGFR—sarcoma	7.09e-05	0.000218	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NRAS—sarcoma	6.92e-05	0.000212	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—SRC—sarcoma	6.9e-05	0.000212	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CTNNB1—sarcoma	6.86e-05	0.00021	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KIT—sarcoma	6.82e-05	0.000209	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KRAS—sarcoma	6.74e-05	0.000207	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—KRAS—sarcoma	6.7e-05	0.000206	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SRC—sarcoma	6.66e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRAS—sarcoma	6.64e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CREB1—sarcoma	6.49e-05	0.000199	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—sarcoma	6.49e-05	0.000199	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRAS—sarcoma	6.41e-05	0.000197	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—sarcoma	6.3e-05	0.000193	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—SRC—sarcoma	6.2e-05	0.00019	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MDM2—sarcoma	6.13e-05	0.000188	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1R—sarcoma	6.08e-05	0.000186	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—sarcoma	6.05e-05	0.000186	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—sarcoma	6.04e-05	0.000185	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MYC—sarcoma	5.97e-05	0.000183	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NRAS—sarcoma	5.97e-05	0.000183	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KRAS—sarcoma	5.95e-05	0.000183	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—sarcoma	5.84e-05	0.000179	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FOXO1—sarcoma	5.79e-05	0.000177	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDGFRB—sarcoma	5.78e-05	0.000177	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HRAS—sarcoma	5.73e-05	0.000176	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KRAS—sarcoma	5.72e-05	0.000175	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRAS—sarcoma	5.7e-05	0.000175	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDGFRA—sarcoma	5.69e-05	0.000174	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KRAS—sarcoma	5.52e-05	0.000169	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—sarcoma	5.48e-05	0.000168	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—sarcoma	5.44e-05	0.000167	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MDM2—sarcoma	5.37e-05	0.000165	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCND1—sarcoma	5.34e-05	0.000164	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—JUN—sarcoma	5.33e-05	0.000163	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CTNNB1—sarcoma	5.29e-05	0.000162	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KRAS—sarcoma	5.14e-05	0.000158	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HRAS—sarcoma	5.06e-05	0.000155	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—sarcoma	4.9e-05	0.00015	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HRAS—sarcoma	4.86e-05	0.000149	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—sarcoma	4.8e-05	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KDR—sarcoma	4.79e-05	0.000147	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SRC—sarcoma	4.78e-05	0.000147	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRAS—sarcoma	4.69e-05	0.000144	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—JUN—sarcoma	4.67e-05	0.000143	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—sarcoma	4.66e-05	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTNNB1—sarcoma	4.63e-05	0.000142	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRAS—sarcoma	4.6e-05	0.000141	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KIT—sarcoma	4.41e-05	0.000135	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HRAS—sarcoma	4.37e-05	0.000134	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MYC—sarcoma	4.29e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CREB1—sarcoma	4.2e-05	0.000129	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—sarcoma	4.19e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SRC—sarcoma	4.19e-05	0.000128	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRAS—sarcoma	4.03e-05	0.000124	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KRAS—sarcoma	3.96e-05	0.000121	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—sarcoma	3.67e-05	0.000113	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ENO2—sarcoma	3.59e-05	0.00011	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HBA1—sarcoma	3.56e-05	0.000109	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—sarcoma	3.52e-05	0.000108	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MDM2—sarcoma	3.47e-05	0.000106	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KRAS—sarcoma	3.47e-05	0.000106	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRAS—sarcoma	3.37e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—sarcoma	3.1e-05	9.52e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLCG1—sarcoma	3.04e-05	9.33e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCND1—sarcoma	3.02e-05	9.28e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—JUN—sarcoma	3.02e-05	9.26e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CTNNB1—sarcoma	3e-05	9.19e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HRAS—sarcoma	2.95e-05	9.04e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SRC—sarcoma	2.71e-05	8.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—sarcoma	2.64e-05	8.09e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRAS—sarcoma	2.6e-05	7.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MYC—sarcoma	2.43e-05	7.44e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—sarcoma	2.37e-05	7.28e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ENO2—sarcoma	2.37e-05	7.25e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HBA1—sarcoma	2.35e-05	7.21e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KRAS—sarcoma	2.24e-05	6.88e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLCG1—sarcoma	2.01e-05	6.16e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—sarcoma	1.99e-05	6.11e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRAS—sarcoma	1.91e-05	5.84e-05	CbGpPWpGaD
